Radient Technologies (Radient Technologies) Debt-to-Asset : 0.49 (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies Debt-to-Asset?

Radient Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $9.49 Mil. Radient Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.51 Mil. Radient Technologies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2022 was $20.61 Mil. Radient Technologies's debt to asset for the quarter that ended in Dec. 2022 was 0.48.

Radient Technologies Debt-to-Asset Historical Data

The historical data trend for Radient Technologies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies Debt-to-Asset Chart

Radient Technologies Annual Data

Trend

Dec13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Debt-to-Asset

Get a 7-Day Free Trial

0.08

0.11

0.26

0.41

0.49

Radient Technologies Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Debt-to-Asset	Get a 7-Day Free Trial															0.46	0.49	0.49	0.48	0.49

Competitive Comparison of Radient Technologies's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radient Technologies's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Radient Technologies's Debt-to-Asset falls into.

Radient Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Radient Technologies's Debt-to-Asset for the fiscal year that ended in Mar. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(10.657	+	0.127)	/	21.908
	=	0.49

Radient Technologies's Debt-to-Asset for the quarter that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(9.488	+	0.506)	/	20.607
	=	0.48

Radient Technologies (OTCPK:RDDTF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Radient Technologies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Radient Technologies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Radient Technologies (Radient Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4

Website

https://www.radientinc.com

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.